Lazard Asset Management
CELU icon

Lazard Asset Management’s Celularity CELU Stock Holding History

Lazard Asset Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-372
Closed -$12K – 2334
2022
Q2 		$12K Sell
372
-577
-61% -$46.9K ﹤0.01% 2188
2022
Q1 		$82K Buy
949
+8
+0.9% +$479 ﹤0.01% 1488
2021
Q4 		$48K Buy
+941
New +$60.2K ﹤0.01% 1755

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LDFO
Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Lazard Asset Management's CELU Position: Q3 2022 in Review

Lazard Asset Management sold out of Celularity (CELU) in Q3 2022, closing a stake of 372 shares — an estimated $12K sold.

Lazard Asset Management first reported a position in CELU in Q4 2021 and held it in 3 quarters. The position peaked at $82K in Q1 2022. 72 funds tracked by Wall St. Rank hold CELU as of Q3 2022.

  • Lazard Asset Management reported no remaining Celularity position as of Q3 2022 after selling out during the quarter.
  • Lazard Asset Management sold 372 Celularity shares in Q3 2022, an estimated $12K.
  • Lazard Asset Management first reported a position in Celularity in Q4 2021 and held it in 3 quarters.
  • Lazard Asset Management's Celularity position peaked at $82K in Q1 2022.
  • 72 funds tracked by Wall St. Rank held Celularity as of Q3 2022.

Based on Lazard Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.